Hardy v. New Jersey Manufacturers Insurance Company

District Court, M.D. Louisiana·Decided June 1, 2023·No. 3:22-cv-00153·Unknown

Opinion

UNITED STATES DISTRICT COURT

MIDDLE DISTRICT OF LOUISIANA

ROSALYN HARDY CIVIL ACTION

VERSUS NO. 22-153-SDD-RLB

NEW JERSEY MANUFACTURERS INSURANCE COMPANY, ET AL.

ORDER

Before the Court is David G. Ferachi, M.D.’s Motion to Quash and/or for Protective Order (R. Doc. 40) and Baton Rouge Orthopaedic Clinic’s (“BROC”) Motion to Quash and/or for Protective Order (R. Doc. 44). Dr. Ferachi and BROC filed a Supplemental Memorandum. (R. Doc. 50). The motions are opposed. (R. Doc. 54). Dr. Ferachi and BROC filed a Reply Memorandum. (R. Doc. 58). I. Background This is a personal injury action involving a motor vehicle accident on or about August 7, 2021. (R. Doc. 1-1). The instant dispute pertains to the scope of subpoenas served on Dr. Ferachi and BROC, in which Dr. Ferachi practices. The Court has previously extended the expert discovery deadline for the purpose of finding the instant subpoenas to be timely. (R. Doc. 52 at 16). New Jersey Manufacturers Insurance Company and Quan D. Dunlap (collectively, “Defendants”) have represented that on August 16, 2021, Plaintiff first initiated treatment with Dr. Thomas Rathmann, a chiropractor, who recommended cervical and lumbar MRIs and then referred Plaintiff to pain management with Dr. Barrett Johnston. (R. Doc. 31-1 at 1; R. Doc. 54 at 1-2). Defendants represent that Dr. Johnston referred Plaintiff to Dr. Eric Oberlander. (R. Doc. 31-1 at 2). Dr. Oberlander, a neurosurgeon, reviewed Plaintiff’s cervical and lumbar MRIs on October 5, 2021, stating, among other things, that she is “a candidate for an ACDF [anterior cervical discectomy with fusion] [at the C5-C7 level] at any point should she continue to fail conservative treatment” and also “may need a lumbar surgery someday.” (R. Doc. 23-3 at 6). Plaintiff represents that she has had five epidural steroid injections related to her injuries. (R. Doc. 34 at 2). Defendants represent that Dr. Johnson has recommended Plaintiff to receive

epidural steroid injections in her lumbar spine for the rest of her life. (R. Doc. 31-1 at 2; R. Doc. 54 at 2). On January 10, 2023, Defendants disclosed to Plaintiff the expert report of Dr. Patrick Juneau. (R. Doc. 23-4 at 1-6; see R. Doc. 23-5 at 3). Dr. Juneau opined in his expert report that he did not “see any neural impingement” based on Plaintiff’s cervical and lumbar MRIs. (R. Doc. 23-4 at 5). In addition, Dr. Juneau opined that Plaintiff does not need “surgical intervention upon her lumbar spine or upon her cervical spine” or “any further steroid injunctions, such as medial branch blocks or epidurals” given that Plaintiff is “essentially at maximum medical improvement at this point.” (R. Doc. 23-4 at 4).

On February 2, 2023, Plaintiff informed Defendants that she planned “to retain” a “rebuttal” expert witness, and Defendants objected to any rebuttal report as untimely. (R. Doc. 23-5 at 2-3). The next day, Plaintiff informed Defendants that Dr. Ferachi, an orthopedic surgeon, was the proposed rebuttal expert. (R. Doc. 23-5 at 1). Plaintiff formally identified Dr. Ferachi as the rebuttal expert on February 6, 2023. (R. Doc. 23-6 at 1). There is no dispute that Dr. Ferachi was retained by Plaintiff solely to provide a rebuttal to Dr. Juneau’s report, and has not treated Plaintiff. (R. Doc. 50). On February 7, 2023, Dr. Ferachi provided Defendants with a 1-page rebuttal report opining that Plaintiff’s cervical MRI shows “evidence of cervical degenerative disc disease with spondylosis from C5 through C7” and that Plaintiff “has worse than right neuroforaminal narrowing at C5-C6, as well as C6-C7.” (R. Doc. 23-6 at 3). Dr. Ferachi further opines that if Plaintiff “failed at least three months of conservative care, then she would be a candidate for C5 through C7 anterior cervical discectomy and fusion.” (R. Doc. 23-6 at 3).1 The Court has held that the rebuttal disclosure was timely pursuant to Rule 26(a)(2)(D)(ii) of the Federal Rules of

Civil Procedure, although the scope of the expert rebuttal disclosure could be challenged by the filing of an appropriate motion in limine or Daubert motion before the district judge. (R. Docs. 18, 29). On February 9, 2023, Defendants provided Plaintiff with the “supplemental” report of Dr. Juneau. (R. Doc. 23-4). In relevant part, this supplemental report provides that based on review of Dr. Oberlander’s deposition and explanation of Plaintiff’s cervical MRI, Dr. Juneau needed to make “some clarification” of his earlier report to clarify that while he “did not see any neural impingement” at the C5-7 level in his original report, a “more accurate description is that Plaintiff “does not have any impingement upon the spinal cord at that level.” (R. Doc. 23-4 at 1).

On March 15, 2023, Defendants issued subpoenas to Dr. Ferachi (R. Doc. 34-1 at 17-22) (seeking the production of 27 categories of documents and electronically stored information on April 5, 2023 in New Orleans, Louisiana) and BROC (R. Doc. 44-2) (seeking the production of 27 categories of documents and electronically stored information on April 5, 2023 in New Orleans, Louisiana). These subpoenas are the subject of the instant motions.

1 Plaintiff subsequently sought to file Dr. Ferachi’s report into the record. (R. Doc. 19). Given that the motion did not present a dispute regarding the contents of the report, the Court denied the motion pursuant to Rule 5(d)(1)(A) of the Federal Rules of Civil Procedure. (R. Doc. 22). In denying the motion, the Court specifically noted that a rebuttal report could be disclosed to Defendants as allowed under Rule 26(a)(2)(D)(ii). (R. Doc. 22). On March 27, 2023, the Court stayed any obligations to respond to the subpoenas pending further order of the Court, and required Plaintiff’s counsel to notify Dr. Ferachi of this stay of any obligations to respond to the subpoenas. (R. Doc. 38). The Court also informed the parties that the deposition of Dr. Ferachi may proceed on April 11, 2023, as agreed upon by the parties pursuant to Local Rule 26(d)(1). (R. Doc. 38).

Through the instant motions, Dr. Ferachi and BROC seek an order quashing the subpoenas served upon on them on the bases that they are overly broad and unduly burdensome; they seek personal and confidential information of patients other than Plaintiff; they seek information that is otherwise confidential or privileged; they seek information that is not proportional to the needs of the case not likely to lead to the discovery of admissible evidence; they seek information for which the production would violate the Health Insurance Portability and Accountability Act of 1996 (HIPAA) or other privacy interest; and they are so oppressive as to constitute harassment or annoyance. (R. Docs. 40, 44).2 II. Law and Analysis

A. Legal Standards “Unless otherwise limited by court order, the scope of discovery is as follows: Parties may obtain discovery regarding any non-privileged matter that is relevant to any party’s claim or defense and proportional to the needs of the case, considering the importance of the issues at stake in the action, the amount in controversy, the parties’ relative access to relevant information, the parties’ resources, the importance of the discovery in resolving the issues, and whether the burden or expense of the proposed discovery outweighs its likely benefit. Information within

2 Drs. Rathmann and Johnson co-filed the Motion to Quash and/or for Protective Order filed by Dr. Ferachi. (See. R. Doc. 40). The Court quashed the motions served upon those treating physicians as untimely. (R. Doc. 52). this scope of discovery need not be admissible in evidence to be discoverable.” Fed. R. Civ. P. 26(b)(1).

Free access — add to your briefcase to read the full text and ask questions with AI

Hardy v. New Jersey Manufacturers Insurance Company, (M.D. La. 2023).

Hardy v. New Jersey Manufacturers Insurance Company (Hardy v. New Jersey Manufacturers Insurance Company) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

In Re Terra International, Inc.
134 F.3d 302 (Fifth Circuit, 1998)
United States v. Garrett
571 F.2d 1323 (Fifth Circuit, 1978)